Jupiter Neurosciences Statistics
Total Valuation
JUNS has a market cap or net worth of $12.16 million. The enterprise value is $14.63 million.
Important Dates
The last earnings date was Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
JUNS has 43.42 million shares outstanding. The number of shares has increased by 15.58% in one year.
| Current Share Class | 43.42M |
| Shares Outstanding | 43.42M |
| Shares Change (YoY) | +15.58% |
| Shares Change (QoQ) | -7.66% |
| Owned by Insiders (%) | 37.97% |
| Owned by Institutions (%) | 4.42% |
| Float | 26.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 300.60 |
| Forward PS | 1.02 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 361.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.51
| Current Ratio | 0.51 |
| Quick Ratio | 0.35 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -50.88 |
Financial Efficiency
Return on equity (ROE) is -6,529.17% and return on invested capital (ROIC) is -219.33%.
| Return on Equity (ROE) | -6,529.17% |
| Return on Assets (ROA) | -130.92% |
| Return on Invested Capital (ROIC) | -219.33% |
| Return on Capital Employed (ROCE) | 335.33% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $8,090 |
| Profits Per Employee | -$1.84M |
| Employee Count | 5 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | -75.00% |
| 50-Day Moving Average | 0.31 |
| 200-Day Moving Average | 0.82 |
| Relative Strength Index (RSI) | 54.59 |
| Average Volume (20 Days) | 3,558,213 |
Short Selling Information
The latest short interest is 625,772, so 1.44% of the outstanding shares have been sold short.
| Short Interest | 625,772 |
| Short Previous Month | 87,758 |
| Short % of Shares Out | 1.44% |
| Short % of Float | 2.32% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, JUNS had revenue of $40,448 and -$9.18 million in losses. Loss per share was -$0.26.
| Revenue | 40,448 |
| Gross Profit | -2.00M |
| Operating Income | -9.33M |
| Pretax Income | -9.18M |
| Net Income | -9.18M |
| EBITDA | n/a |
| EBIT | -9.33M |
| Loss Per Share | -$0.26 |
Full Income StatementBalance Sheet
The company has $2.36 million in cash and $4.83 million in debt, giving a net cash position of -$2.47 million or -$0.06 per share.
| Cash & Cash Equivalents | 2.36M |
| Total Debt | 4.83M |
| Net Cash | -2.47M |
| Net Cash Per Share | -$0.06 |
| Equity (Book Value) | -2.78M |
| Book Value Per Share | -0.08 |
| Working Capital | -3.32M |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.78M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 5.43M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -23,075.85% |
| Pretax Margin | -22,690.83% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |